Loading...
PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy
Cancer immunotherapy has greatly advanced in recent years, and PD-1/PD-L1 blocking therapy has become a major pillar of immunotherapy. Successful clinical trials of PD-1/PD-L1 blocking therapies in cancer treatments have benefited many patients, which promoted the Food and Drug Administration (FDA)...
Na minha lista:
| Udgivet i: | Cancer Biol Med |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Chinese Anti-Cancer Association
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5994550/ https://ncbi.nlm.nih.gov/pubmed/29951336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20892/j.issn.2095-3941.2017.0086 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|